AFP and hepatocellular carcinoma: Among several tissue-specific promoters, the α-fetoprotein (AFP) promoter is a promising candidate for providing oncolytic Ads with specificity toward HCC; this is because AFP is preferentially overexpressed in 70% of patients with liver cancer15.